HSCS – heartsciences inc. (US:NASDAQ)
Stock Stats
News
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Heart Test Laboratories, Inc. (NASDAQ: HSCS) had its "buy" rating re-affirmed by analysts at Ascendiant Capital Markets. They now have a $15.00 price target on the stock.
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
Form 8-K HeartSciences Inc. For: Nov 07
Form 8-K/A HeartSciences Inc. For: Oct 11
Form 8-K Heart Test Laboratories, For: Oct 11
Form S-1/A Heart Test Laboratories,
Form DEFA14A Heart Test Laboratories,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.